arrow_back Trending Legislation
Share share

Kidney Care Improvement Act: Screening, Innovation, and Medigap Access for ESRD Patients

This Act aims to enhance care for individuals with Chronic Kidney Disease (CKD) by including screening within Medicare's annual wellness visits. It increases access to kidney disease education and ensures that End-Stage Renal Disease (ESRD) patients under 65 are guaranteed access to Medigap supplemental insurance. Furthermore, the legislation modifies Medicare payment systems to support innovative therapies and drugs for dialysis patients.
Key points
Chronic kidney disease (CKD) screening will be included in Medicare's annual wellness visits (effective January 1, 2025).
ESRD patients under 65 will gain guaranteed access to Medigap supplemental insurance (effective January 1, 2026).
Access to Kidney Disease Education (KDE) is expanded, allowing more professionals and dialysis facilities to provide these services.
Introduction of permanent add-on payments in Medicare for new drugs and biological products used in dialysis that previously received a transitional payment adjustment.
Mandates studies on factors affecting kidney disease progression and transplantation rates, particularly within minority populations.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Chronic Kidney Disease Improvement in Research and Treatment Act of 2024
Print number: S 4469
Sponsor: Sen. Cardin, Benjamin L. [D-MD]
Process start date: 2024-06-05